Coronavirus (COVID-19) Update: FDA Authorizes Additional Monoclonal Antibody for Treatment of COVID-19

The FDA issued an emergency use authorization for the investigational monoclonal antibody therapy sotrovimab for the treatment of mild-to-moderate COVID-19 in adult and pediatric patients.